Cargando…

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review

Although early aggressive and prolonged treatment with specific antibiotics can extend survival in patients with cystic fibrosis (CF) colonized by opportunistic Pseudomonas aeruginosa (PA), antibiotics fail to eradicate the infecting multidrug-resistant (MDR) PA strains in CF. Century-long research...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossitto, Martina, Fiscarelli, Ersilia V., Rosati, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945972/ https://www.ncbi.nlm.nih.gov/pubmed/29780361 http://dx.doi.org/10.3389/fmicb.2018.00775

Ejemplares similares

In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis
por: Fiscarelli, Ersilia Vita, et al.
Publicado: (2021)

Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy
por: Rossitto, Martina, et al.
Publicado: (2021)

A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm
por: Pompilio, Arianna, et al.
Publicado: (2015)

Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models
por: Forti, Francesca, et al.
Publicado: (2018)

The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
por: Essoh, Christiane, et al.
Publicado: (2013)

In vitro Activity of Antivirulence Drugs Targeting the las or pqs Quorum Sensing Against Cystic Fibrosis Pseudomonas aeruginosa Isolates
por: Collalto, Diletta, et al.
Publicado: (2022)

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Anti-Virulence Properties of Coridothymus capitatus Essential Oil against Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Vrenna, Gianluca, et al.
Publicado: (2021)

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection
por: Martin, Isaac, et al.
Publicado: (2023)

Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status
por: Hraiech, Sami, et al.
Publicado: (2015)

Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic Fibrosis
por: Krylov, Victor, et al.
Publicado: (2016)

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention
por: Morello, Eric, et al.
Publicado: (2011)

Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
por: Ambroa, Antón, et al.
Publicado: (2020)

Analysis of Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis Revealed Novel Groups of Filamentous Bacteriophages
por: Evseev, Peter, et al.
Publicado: (2023)

Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
por: Olszak, Tomasz, et al.
Publicado: (2015)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
por: Rada, Balázs
Publicado: (2017)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
por: Pompilio, Arianna, et al.
Publicado: (2012)

Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2019)

Clonal Diversity, Biofilm Formation, and Antimicrobial Resistance among Stenotrophomonas maltophilia Strains from Cystic Fibrosis and Non-Cystic Fibrosis Patients
por: Pompilio, Arianna, et al.
Publicado: (2020)

Variability in Bacteriophage and Antibiotic Sensitivity in Serial Pseudomonas aeruginosa Isolates from Cystic Fibrosis Airway Cultures over 12 Months
por: Martin, Isaac, et al.
Publicado: (2021)

Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy
por: Abdelghafar, Aliaa, et al.
Publicado: (2023)

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients
por: van Mansfeld, Rosa, et al.
Publicado: (2016)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
por: Lingner, Meike, et al.
Publicado: (2017)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Zhao, Jingming, et al.
Publicado: (2018)

Anti-Virulence Activity of the Cell-Free Supernatant of the Antarctic Bacterium Psychrobacter sp. TAE2020 against Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Papa, Rosanna, et al.
Publicado: (2021)

Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
por: Hauber, Hans-Peter, et al.
Publicado: (2008)

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
por: Pukhalsky, A L, et al.
Publicado: (1999)

Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice
por: Wang, Yufa, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bhompkrmera3juvt46mop8tgq5